Epidemic characteristics of alcohol‐related liver disease in Asia from 2000 to 2020: A systematic review and meta‐analysis

医学 肝细胞癌 肝硬化 酒精性肝病 内科学 荟萃分析 置信区间 肝病 胃肠病学 生物 生物化学
作者
Hongqin Xu,Peng Xiao,Feiyu Zhang,Tao Liu,Yanhang Gao
出处
期刊:Liver International [Wiley]
卷期号:42 (9): 1991-1998 被引量:21
标识
DOI:10.1111/liv.15312
摘要

To systematically summarize the prevalence of alcohol-related liver disease (ALD) and the alcohol-attributable proportions of liver cirrhosis and hepatocellular carcinoma (HCC) cases in Asia.The Embase, PubMed, Web of Science, Cochrane, CINAHL, WanfangMed and China National Knowledge Infrastructure databases were searched from 01 January 2000 to 01 December 2021 for reports of ALD prevalence and alcohol-attributable proportions of liver cirrhosis/HCC in Asian populations. Study characteristics were extracted, and meta-analyses were conducted.Our literature search identified 13 studies reporting the ALD prevalence, 62 studies reporting the alcohol-attributable proportion of liver cirrhosis and 34 studies reporting the alcohol-attributable proportion of HCC. The overall prevalence of ALD was 4.81% (95% confidence interval [CI] 3.67%, 6.09%). The ALD prevalence was higher in men (7.80% [95% CI 5.70%, 10.19%]) than in women (0.88% [95% CI 0.35%, 1.64%]) and increased significantly over time from 3.82% (95% CI 2.74%, 5.07%) between 2000 and 2010 to 6.62% (95% CI 4.97%, 8.50%) between 2011 and 2020. Among 469 640 cases of liver cirrhosis, the pooled alcohol-attributable proportion was 12.57% (95% CI 10.20%, 15.16%). Among 82 615 HCC cases, the pooled alcohol-attributable proportion was 8.30% (95% CI 6.10%,11.21%). Significant regional differences were observed in alcohol-attributable proportions of liver cirrhosis and HCC.The prevalence of ALD and the proportions of alcohol-related liver cirrhosis and HCC in Asia are lower than those in western populations. However, a gradual increasing trend was observed over the last 21 years. ALD is likely to emerge as a leading cause of chronic liver disease in Asia.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
咕噜仔完成签到,获得积分10
1秒前
汉堡包应助科研通管家采纳,获得10
1秒前
1秒前
Orange应助科研通管家采纳,获得10
1秒前
1秒前
浮游应助科研通管家采纳,获得10
1秒前
领导范儿应助科研通管家采纳,获得10
1秒前
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
情怀应助科研通管家采纳,获得10
1秒前
小二郎应助科研通管家采纳,获得30
1秒前
Hello应助科研通管家采纳,获得10
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
脑洞疼应助科研通管家采纳,获得10
2秒前
所所应助科研通管家采纳,获得10
2秒前
LewisAcid应助科研通管家采纳,获得10
2秒前
浮游应助科研通管家采纳,获得10
2秒前
浮游应助科研通管家采纳,获得10
2秒前
桐桐应助科研通管家采纳,获得10
2秒前
香蕉诗蕊举报Llll求助涉嫌违规
2秒前
2秒前
CipherSage应助科研通管家采纳,获得10
2秒前
orixero应助科研通管家采纳,获得10
2秒前
打发打发的发到付电费完成签到,获得积分10
2秒前
维奈克拉应助科研通管家采纳,获得20
2秒前
哈哈发布了新的文献求助10
2秒前
桐桐应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
顾矜应助科研通管家采纳,获得10
2秒前
科研通AI6应助科研通管家采纳,获得10
2秒前
dew应助fugdu采纳,获得10
2秒前
斯文败类应助科研通管家采纳,获得30
2秒前
酷波er应助科研通管家采纳,获得10
2秒前
zhonglv7应助科研通管家采纳,获得10
2秒前
lilili应助科研通管家采纳,获得10
2秒前
周杰完成签到,获得积分10
3秒前
3秒前
EIS完成签到,获得积分10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
花の香りの秘密―遺伝子情報から機能性まで 800
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Chemistry and Biochemistry: Research Progress Vol. 7 430
Biotechnology Engineering 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5629991
求助须知:如何正确求助?哪些是违规求助? 4721324
关于积分的说明 14972153
捐赠科研通 4788008
什么是DOI,文献DOI怎么找? 2556688
邀请新用户注册赠送积分活动 1517740
关于科研通互助平台的介绍 1478342